WASHINGTON, DC - The Food Marketing Institute (FMI) filed comments yesterday in response to the Food and Drug Administration (FDA)’s request for scientific data and information about products containing cannabis or cannabis-derived compounds. The 2018 Farm Bill allows for the production and commercialization of hemp and hemp-derivatives like cannabidiol (CBD), but the new law explicitly preserves FDA’s authority over the use of such ingredients in FDA-regulated products.
↧